TG Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · North Carolina, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
3020 Carrington Mill Blvd Ste 475, Morri...Phone Number
(212) 554-4484Website
www.tgtherapeutics.comRevenue
$799.5 MillionStock Symbol
TGTXIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
3
3
1
1
2
2
About TG Therapeutics
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in New York City, New York.Explore more
TG Therapeutics Org Chart
SC
Senior Director (Analytics & Insights)
IH
Senior Director, Marketing
KS
Regional Director, Marketing
AH
Regional Marketing Director - East
MV
Director, Patient Marketing
LF
Regional Director, Marketing Team
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TG Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if TG Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at TG Therapeutics
Earning: See what the market has to say on TG Therapeutics recently announced quarterly report
Click to see if TG Therapeutics had a recent Job posting/layoffs
Check out if TG Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once TG Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
TG Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when TG Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined TG Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to TG Therapeutics
Compare insights from companies similar to TG Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
TG Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
TG Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about TG Therapeutics.
TG Therapeutics financials insights
Gather financial insights about TG Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Debt
$140M
TG Therapeutics Tech Stack
A closer look at the technologies used by TG Therapeutics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
TG Therapeutics News & Media
TG Therapeutics, Inc. (TGTX) Q2 2026 Earnings Call Transcript
TG Therapeutics, Inc. (TGTX) Q2 2026 Earnings Call August 3, 2026 8:30 AM EDTCompany ParticipantsJenna Bosco - Senior Vice President of Corporate...TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance
Second quarter 2026 total global revenue of approximately $240 million, including BRIUMVI U.S. net product revenue of approximately $228 millionTG Therapeutics to Host Conference Call on Second Quarter 2026 Financial Results and Business Update
Conference Call to be Held Monday, August 3, 2026, at 8:30 am ET Conference Call to be Held Monday, August 3, 2026, at 8:30 am ET2 Fast-Growing Pharmaceutical Stocks to Buy Now
Incyte and TG Therapeutics are seeing strong share growth, backed up by booming revenue and earnings.
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding TG Therapeutics
Sign Up For FreeTo access detailed company insights
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in New York City, New York.... Read More
